Significant international effort has been invested and will continue to be invested to develop novel gene therapies for retinal degenerative conditions, which have eluded more traditional approaches [42,43], partly because retinas are relatively easy to access and there is prior success with RPE65 associated retinal degeneration [44]. The gene discussed is RPE65; the disease is retinal degeneration.